Search
for
Sort by
Research 61–90 of 1000+
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Novel therapies for alopecia areata: The era of rational drug development
- Janus kinase inhibitors for alopecia areata
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- A review of Janus kinase inhibitor use in scarring alopecia
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Janus kinase inhibitors for alopecia areata: A narrative review
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Current and future pharmacotherapy for alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Pharmacological Treatment of Alopecia
- Alopecia Areata
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Alopecia Areata
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Alopecia Areata: Current Review